Abstract
Ebola virus causes a lethal hemorrhagic disease for which no therapy or vaccine is currently approved. Recently, the crystal structure of the Ebola virus glycoprotein in complex with a human neutralizing antibody was illuminated, providing a path from the shadows toward understanding cellular attachment, viral fusion, and immune evasion.
Original language | English |
---|---|
Pages (from-to) | 87-89 |
Number of pages | 3 |
Journal | Cell Host and Microbe |
Volume | 4 |
Issue number | 2 |
DOIs | |
State | Published - Aug 14 2008 |